Target intelligence / Profile preview

Phosphatidylinositol glycan anchor biosynthesis class H pseudogene 1 (PIGHP1)

Target: PIGHP1

Overview

Phosphatidylinositol glycan anchor biosynthesis class H pseudogene 1 (PIGHP1) is annotated as a pseudogene in the human genome. Pseudogenes are defunct genomic DNA sequences that resemble functional genes but are usually non-coding due to mutations or truncations. PIGHP1 does not encode a functional protein and is not involved in biochemical pathways relevant to drug discovery or disease mechanisms. It is not considered a therapeutic target, nor is it associated with known disease mechanisms, phenotypes, or drug interactions.

Beyond the preview

Go deeper on Phosphatidylinositol glycan anchor biosynthesis class H pseudogene 1 (PIGHP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol glycan anchor biosynthesis class H pseudogene 1 (PIGHP1).

Explore the full profile